Upstream Bio, Inc.

UPBReported to SECin USCIK 0002022626Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at Upstream Bio, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Deykin AaronChief Medical OfficerOpen-market sell$4,914895 sharesSep 17, 2026Deykin AaronChief Medical Officer$4,914Sell · Sep 17Open-market sell895Sep 17, 2026
Sutherland Everett RandChief Executive OfficerOpen-market sell$11,5022,095 sharesSep 17, 2026Sutherland Everett RandChief Executive Officer$11,502Sell · Sep 17Open-market sell2,095Sep 17, 2026
Houghton AdamChief Business OfficerOpen-market sell$3,843700 sharesSep 17, 2026Houghton AdamChief Business Officer$3,843Sell · Sep 17Open-market sell700Sep 17, 2026
GRAY MICHAELCFO and COOOpen-market sell$4,683853 sharesSep 17, 2026GRAY MICHAELCFO and COO$4,683Sell · Sep 17Open-market sell853Sep 17, 2026
Ambrose AllisonGeneral CounselOpen-market sell$2,663485 sharesSep 17, 2026Ambrose AllisonGeneral Counsel$2,663Sell · Sep 17Open-market sell485Sep 17, 2026